Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roundup Cancer Designation Led To Scientists Receiving Threatening Letters From Monsanto December 4, 2017 Irvin Jackson Add Your CommentsAmid continuing debate worldwide about the potential cancer risks associated with Roundup, a number of scientists indicate that they were apparently threatened by Monsanto, the manufacturer of the widely used weedkiller, which the company has taken the “scorched earth” policy of defending in recent months.ย Environmental Health News published a story on November 20, detailing how Monsanto attempted to strike back at independent researchers after a March 2015 decision by the World Health Organization’s International Agency for Research on Cancer, which classified the active ingredient in their blockbuster product as a probable human carcinogen.The story is the first in a series called “Monsanto Papers,” which was originally published in June in the French publication Le Monde, and was just recently translated to English. The name was later given to a number of damning internal documents from Monsanto, which were revealed as part of the ongoing U.S. litigation against Monsanto by farmers, landscapers and other individuals who indicate they developed non-Hodgkin lymphoma following exposure to Roundup.ROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe memos and emails suggest that the company has known that its herbicide might be dangerous for years, put out ghostwritten studies that were falsely portrayed as the work of independent scientists, and unduly influenced regulators in the U.S. and Europe to avoid any indication that Roundup is not safe. The company even went as far as writing some parts of the safety reviews for regulators, and asked them to squash government inquiries that they could not write themselves, some of the documents suggest.After the IARC ruling, the report indicates that Monsanto wasted no time in attacking the IARC and its scientists. A number of international scientists who were part of the IARC’s review of glyphosate received what they referred to as threatening and intimidating letters from Monsanto. While politely worded, the letters order them to turn over all of their files, or preserve them for pending legal action in U.S. court. The company did not send those letters to U.S. scientists who worked with the IARC, however.The scientists did not take well to the request, with many firing back at Monsanto, calling the company out on what they saw as veiled threats.“After talking with some of my colleagues, who participated to the IARC meeting, I found your letter intimidating and noxious even though transparency is important,” Consolato Maria Sergi, a pathologist at the University of Alberta wrote in a response letter. “The use of language should be meticulous, respectful and professional. It is impolitic to mention possible consequences without identifying the correct background. I find your approach reprehensive and lacking of common courtesy even by today’s standards.”While Monsanto attempted to dismiss the IARC report as “junk science,” and challenged the group’s validity and scientific methods at every turn, the Monsanto Papers reveal that the company’s own observer of the IARC’s review, Tom Sorahan, a professor at the University of Birmingham in the U.K., reported back that the IARC had done it right.Sorahan sent an email to Monsanto saying that the IARC followed proper procedures, were friendly and responded to all of his comments during the final meeting of their review.Sorahan’s analysis, as the only Monsanto observer who actually attended the IARC final review meeting, is never mentioned in Monsanto’s attacks against the IARC. It’s existence is only likely known due to the release of the Monsanto Papers.Roundup LitigationThroughout the U.S., several thousand Roundup lawsuits have been filed against Monsanto by farmers, landscapers, agricultural workers and others regularly exposed to Roundup, alleging that they may have avoided a diagnosis of non-Hodgkins lymphoma or other cancer if warnings had been provided by Monsanto.Since October 2016, all federal casesย have been consolidated for pretrial proceedings as part of an MDL, or multidistrict litigation, which is centralized before U.S. District Judge Vince Chhabria in the Northern District of California.As part of the coordinated litigation, it is expected that a small group of bellwether trials will be prepared for early trial dates to help gauge how juries may respond to certain evidence and testimony that will be repeated throughout the cases. However, if Monsanto fails to reachย Roundup settlementsย or another resolution for the failure to warn cases, hundreds of individual lawsuits may eventually be remanded back to the federal courts where they were originally filed for an separate trial dates. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Glyphosate, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup, Weed KillerMore Roundup Lawsuit Stories Roundup Class Action Lawsuit Linked to $7.2B NHL Settlement Transferred to Federal MDL June 2, 2026 MDL Judge Urged To Block $7.25B Roundup Non-Hodgkinโs Lymphoma Settlement April 28, 2026 Judge Grants Preliminary Approval to Roundup Lawsuit Settlement Plan March 5, 2026 0 Comments InstagramThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Depo-Provera Meningioma Side Effects Left Woman With Debilitating Migraines, Lawsuit Claims (Posted: today)A Depo-Provera meningioma lawsuit indicates that a woman suffered permanent and debilitating injuries after needing to have a brain tumor surgically removed.MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Caused Meningioma 29 Years After First Birth Control Shots: Lawsuit (05/22/2026)Depo-Provera Lawsuit Filings Exceed 6,000, As Court Prepares for First Test Trials (05/18/2026)Intracranial Meningioma from Depo-Provera Shots Caused Hearing Loss, Vision Loss: Lawsuit (05/12/2026) Dupixent Injection Lawsuit Alleges Manufacturer Failed to Warn About T-Cell Lymphoma Cancer Side Effects (Posted: yesterday)Regeneron and Sanofi-Aventis face a Dupixent injection lawsuit from a Louisiana woman who says the companies knew about the drug’s risks but downplayed them to doctors and patients.MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Claims Eczema Drug Caused Womanโs CTCL Diagnosis (05/28/2026)Link Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges (05/11/2026)Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy (05/01/2026) Port Catheter Thrombosis Lawsuit Claims Defective AngioDynamics Xcela Device Caused Injury (Posted: 2 days ago)A Nevada woman has filed a lawsuit alleging defects in AngioDynamicsโ port catheters caused her Xcela device to trigger a thrombosis in her right internal jugular vein.MORE ABOUT: ANGIODYNAMICS PORT CATHETER LAWSUITSmartPort Surgery Lawsuit Claims AngioDynamics Catheter Fractured Inside Womanโs Body (05/15/2026)18 AngioDynamics Port Catheter Lawsuits Will Be Selected for Bellwether Discovery in August 2026 (05/05/2026)AngioDynamics Catheter Lawsuit Claims SmartPort Device Embedded in Jugular Vein, Caused Embolism (04/30/2026)
Depo-Provera Meningioma Side Effects Left Woman With Debilitating Migraines, Lawsuit Claims (Posted: today)A Depo-Provera meningioma lawsuit indicates that a woman suffered permanent and debilitating injuries after needing to have a brain tumor surgically removed.MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Caused Meningioma 29 Years After First Birth Control Shots: Lawsuit (05/22/2026)Depo-Provera Lawsuit Filings Exceed 6,000, As Court Prepares for First Test Trials (05/18/2026)Intracranial Meningioma from Depo-Provera Shots Caused Hearing Loss, Vision Loss: Lawsuit (05/12/2026)
Dupixent Injection Lawsuit Alleges Manufacturer Failed to Warn About T-Cell Lymphoma Cancer Side Effects (Posted: yesterday)Regeneron and Sanofi-Aventis face a Dupixent injection lawsuit from a Louisiana woman who says the companies knew about the drug’s risks but downplayed them to doctors and patients.MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Claims Eczema Drug Caused Womanโs CTCL Diagnosis (05/28/2026)Link Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges (05/11/2026)Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy (05/01/2026)
Port Catheter Thrombosis Lawsuit Claims Defective AngioDynamics Xcela Device Caused Injury (Posted: 2 days ago)A Nevada woman has filed a lawsuit alleging defects in AngioDynamicsโ port catheters caused her Xcela device to trigger a thrombosis in her right internal jugular vein.MORE ABOUT: ANGIODYNAMICS PORT CATHETER LAWSUITSmartPort Surgery Lawsuit Claims AngioDynamics Catheter Fractured Inside Womanโs Body (05/15/2026)18 AngioDynamics Port Catheter Lawsuits Will Be Selected for Bellwether Discovery in August 2026 (05/05/2026)AngioDynamics Catheter Lawsuit Claims SmartPort Device Embedded in Jugular Vein, Caused Embolism (04/30/2026)